This PDF is the current document as it appeared on Public Inspection on 07/13/2016 at 08:45 am.
In accordance with sction 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces a meeting for the initial review of applications in response to Funding Opportunity Announcement (FOA) CK17-1701, Emerging Infections Programs.
Time and Date: 10:00 a.m.-5:00 p.m., EDT, August 30-31, 2016 (Closed). Start Printed Page 45507
Status: The meeting will be closed to the public in accordance with provisions set forth in section 552b(c)(4) and (6), title 5 U.S.C., and the determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.
Matters for Discussion: The meeting will include the initial review, discussion, and evaluation of applications received in response to “Emerging Infections Programs”, FOA CK17-1701.
Contact Person for More Information: Gregory Anderson, M.S., M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road NE., Mailstop E60, Atlanta, Georgia 30333, Telephone: (404) 718-8833.
The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.Start Signature
Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.
[FR Doc. 2016-16581 Filed 7-13-16; 8:45 am]
BILLING CODE 4163-18-P